dc.contributor.author |
Kanz, Lothar |
|
dc.date.accessioned |
2019-04-23T05:39:20Z |
|
dc.date.available |
2019-04-23T05:39:20Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
1365-2141 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/87850 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Wiley |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1111/bjh.14920 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20190131163842_00536 |
|
utue.publikation.seiten |
586-597 |
de_DE |
utue.personen.roh |
Einsele, Hermann |
|
utue.personen.roh |
Engelhardt, Monika |
|
utue.personen.roh |
Tapprich, Christoph |
|
utue.personen.roh |
Mueller, Juergen |
|
utue.personen.roh |
Liebisch, Peter |
|
utue.personen.roh |
Langer, Christian |
|
utue.personen.roh |
Kropff, Martin |
|
utue.personen.roh |
Muegge, Lars O. |
|
utue.personen.roh |
Jung, Wolfram |
|
utue.personen.roh |
Wolf, Hans-Heinrich |
|
utue.personen.roh |
Metzner, Bernd |
|
utue.personen.roh |
Hart, Christina |
|
utue.personen.roh |
Gramatzki, Martin |
|
utue.personen.roh |
Hertenstein, Bernd |
|
utue.personen.roh |
Pfreundschuh, Michael |
|
utue.personen.roh |
Roesler, Wolf |
|
utue.personen.roh |
Fischer, Thomas |
|
utue.personen.roh |
Maschmeyer, Georg |
|
utue.personen.roh |
Kanz, Lothar |
|
utue.personen.roh |
Hess, Georg |
|
utue.personen.roh |
Jaeger, Elke |
|
utue.personen.roh |
Bentz, Martin |
|
utue.personen.roh |
Duerk, Heinz A. |
|
utue.personen.roh |
Salwender, Hans |
|
utue.personen.roh |
Hebart, Holger |
|
utue.personen.roh |
Straka, Christian |
|
utue.personen.roh |
Knop, Stefan |
|
dcterms.isPartOf.ZSTitelID |
British Journal of Haematology |
de_DE |
dcterms.isPartOf.ZS-Issue |
4 |
de_DE |
dcterms.isPartOf.ZS-Volume |
179 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |